Parasite Clearance Time and Time to Recurrent Infection Following Treatment With Artemether/Lumefantrine

NCT01998295 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Instantaneous Clearance

Interventions

DRUG: Artemether/lumefantrine

Sponsor

Muhimbili University of Health and Allied Sciences

Collaborators

[object Object]